Loading...
Fresenius Medical Care AG & Co. KGaA
FMS•NYSE
HealthcareMedical - Care Facilities
$28.51
$-0.14(-0.49%)
Fresenius Medical Care AG & Co. KGaA (FMS) Financial Performance & Statements
Review Fresenius Medical Care AG & Co. KGaA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.61%
↓ 0.61%
Operating Income Growth
1.68%
↑ 1.68%
Net Income Growth
7.80%
↑ 7.80%
Operating Cash Flow Growth
-9.23%
↓ 9.23%
Operating Margin
7.58%
↑ 7.58%
Gross Margin
24.46%
↑ 24.46%
Net Profit Margin
3.17%
↑ 3.17%
ROE
4.38%
↑ 4.38%
ROIC
5.42%
↑ 5.42%
Fresenius Medical Care AG & Co. KGaA (FMS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Fresenius Medical Care AG & Co. KGaA stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.08B | $4.76B | $4.77B | $4.72B |
| Cost of Revenue | $3.81B | $3.61B | $3.60B | $3.55B |
| Gross Profit | $1.27B | $1.15B | $1.17B | $1.17B |
| Gross Profit Ratio | $0.25 | $0.24 | $0.24 | $0.25 |
| R&D Expenses | $50.49M | $40.05M | $45.59M | $48.00M |
| SG&A Expenses | $839.82M | $756.15M | $771.47M | $776.00M |
| Operating Expenses | $1.01B | $683.39M | $741.00M | $957.00M |
| Total Costs & Expenses | $4.83B | $4.30B | $4.41B | $4.51B |
| Interest Income | $21.57M | $16.93M | $18.00M | $15.66M |
| Interest Expense | $101.04M | $99.10M | $103.00M | $103.85M |
| Depreciation & Amortization | $0.00 | $366.26M | $387.00M | $387.74M |
| EBITDA | $280.97M | $845.89M | $736.46M | $729.00M |
| EBITDA Ratio | $0.06 | $0.18 | $0.15 | $0.15 |
| Operating Income | $259.39M | $462.00M | $425.00M | $217.00M |
| Operating Income Ratio | $0.05 | $0.10 | $0.09 | $0.05 |
| Other Income/Expenses (Net) | -$79.47M | -$81.47M | -$85.00M | -$88.00M |
| Income Before Tax | $179.93M | $380.53M | $340.00M | $129.00M |
| Income Before Tax Ratio | $0.04 | $0.08 | $0.07 | $0.03 |
| Income Tax Expense | $61.06M | $116.53M | $99.01M | $40.00M |
| Net Income | $66.91M | $213.03M | $187.00M | $70.96M |
| Net Income Ratio | $0.01 | $0.04 | $0.04 | $0.02 |
| EPS | $0.12 | $0.00 | $0.32 | $0.12 |
| Diluted EPS | $0.12 | $0.00 | $0.32 | $0.06 |
| Weighted Avg Shares Outstanding | $586.83M | $0.00 | $586.83M | $586.83M |
| Weighted Avg Shares Outstanding (Diluted) | $586.83M | $0.00 | $586.83M | $1.17B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan